Sivik Global Healthcare LLC Purchases Shares of 3,000 Mettler-Toledo International, Inc. $MTD

Sivik Global Healthcare LLC purchased a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,000 shares of the medical instruments supplier’s stock, valued at approximately $4,183,000. Mettler-Toledo International makes up approximately 1.2% of Sivik Global Healthcare LLC’s holdings, making the stock its 20th largest position.

Several other institutional investors also recently modified their holdings of MTD. Geneos Wealth Management Inc. increased its holdings in shares of Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 30 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Mettler-Toledo International by 23.2% in the second quarter. EverSource Wealth Advisors LLC now owns 287 shares of the medical instruments supplier’s stock valued at $337,000 after buying an additional 54 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Mettler-Toledo International by 1.3% in the second quarter. First Trust Advisors LP now owns 33,900 shares of the medical instruments supplier’s stock valued at $39,823,000 after buying an additional 448 shares in the last quarter. Baird Financial Group Inc. increased its holdings in shares of Mettler-Toledo International by 3.1% in the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after buying an additional 40 shares in the last quarter. Finally, Jump Financial LLC increased its position in shares of Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after acquiring an additional 125 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 800 shares of the stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Up 0.2%

Shares of NYSE:MTD opened at $1,269.09 on Wednesday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The business has a fifty day simple moving average of $1,305.47 and a 200 day simple moving average of $1,364.36. The firm has a market cap of $25.70 billion, a price-to-earnings ratio of 30.13, a P/E/G ratio of 2.64 and a beta of 1.43.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the prior year, the business posted $12.41 EPS. Mettler-Toledo International’s quarterly revenue was up 8.1% on a year-over-year basis. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

MTD has been the topic of several analyst reports. Barclays dropped their target price on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research report on Monday, December 15th. Finally, Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Moderate Buy” and an average target price of $1,463.75.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.